Clinical data on potential treatments for the new coronavirus could help sustain a market bounce that has buoyed stocks after last month's plunge, ...
Clinical data on potential treatments for the new coronavirus could help sustain a market bounce that has buoyed stocks after last month's plunge, as investors look for signs that authorities may be able to stabilize the pandemic.08 Apr 2020 03:45AMNEW YORK: Clinical data on potential treatments for the new coronavirus could help sustain a market bounce that has buoyed stocks after last month's plunge, as investors look for signs that authorities may be able to stabilize the pandemic.
Early signs of a slowdown in hospitalizations and intensive care needs in coronavirus hotspots in the United States and abroad have fed a stock market turnaround sparked by massive support from the Federal Reserve and a more than US$2 trillion government bailout. As of Monday, the S&P 500 was off about 21per cent from its Feb. 19 all-time high but had rebounded 19per cent since March 23.
Drugmakers are studying ways to combat the respiratory illness, for which there are no approved treatments, as hospitals face strains from the flood of patients.More than 330 clinical studies related to COVID-19 are listed in clinicaltrials.gov, a database maintained by the U.S. National Institutes of Health, including many seeking to test drugs already approved for other conditions.
Even if remdesivir proves effective, the amount of the drug that would be available remains a concern. Gilead said last weekend https://www.gilead.com/stories/articles/an-update-on-covid-19-from-our-chairman-and-ceo its existing supply could equate to more than 140,000 courses of treatment.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
S&P 500 set to recoup US$1 trillion in value as virus deaths slowThe S&P 500 was on track to recoup about US$1 trillion in market value in a frantic rally on Monday after New York, the biggest U.S. coronavirus ...
Read more »
Coronavirus: IMF encouraged by China's coronavirus recovery, but says pandemic may flare up againWASHINGTON (REUTERS) - The International Monetary Fund on Monday (April 6) cited limited but encouraging signs of recovery in China, the first country to suffer the brunt of the Covid-19 pandemic, but said it could not rule out a resurgence of the pandemic in China and elsewhere.. Read more at straitstimes.com.
Read more »
India lifts restrictions on 24 drug exports amid coronavirus pandemicNEW DELHI (REUTERS) - India, the world's main supplier of generic drugs, has lifted restrictions on the export of 24 pharmaceutical ingredients and medicines made from them, the government said in a statement.. Read more at straitstimes.com.
Read more »
White House, experts clash over use of drug for coronavirusWhite House trade adviser Peter Navarro on Monday acknowledged that members of the task force dealing with the coronavirus outbreak clashed over ...
Read more »
UN agency says coronavirus emergency could trump some patent rightsDiscussions are under way on enabling wider access to some patented drugs and medical supplies during the coronavirus pandemic, the head of the ...
Read more »
Asia stocks rise on coronavirus slowdown; pound down after Boris Johnson taken to hospitalSYDNEY (REUTERS) - Stocks jumped as investors were encouraged by a slowdown in coronavirus-related deaths and new cases.. Read more at straitstimes.com.
Read more »